<!DOCTYPE html>
<html lang="en" dir="auto">

<head><meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
<meta name="robots" content="index, follow">
<title>FDA Goes Against Its Advisory Panel | Behaviorism and Mental Health</title>
<meta name="keywords" content="">
<meta name="description" content="The FDA recently approved paroxetine (which in higher doses is marketed as the antidepressant Paxil) as a nonhormonal treatment for hot flashes in menopausal women.  The drug will be marketed as Brisdelle.
According to a New York Times article F.D.A. Approves a Drug for Hot Flashes, the approval was granted despite the fact that FDA&rsquo;s own advisory committee voted 10 to 4 last March against approval.
The reported reason for the negative vote was that in clinical trials, Brisdelle proved only minimally effective.">
<meta name="author" content="PhilHickeyPhD">
<link rel="canonical" href="https://behaviorismandmentalhealth.com/posts/fda-goes-against-its-advisory-panel/">
<link crossorigin="anonymous" href="../../assets/css/stylesheet.2211ca3164be7830024f6aad2b3a2e520843a64f8f048445c3401c1249aa051d.css" integrity="sha256-IhHKMWS&#43;eDACT2qtKzouUghDpk&#43;PBIRFw0AcEkmqBR0=" rel="preload stylesheet" as="style">
<link rel="icon" href="https://behaviorismandmentalhealth.com/favicon.ico">
<link rel="icon" type="image/png" sizes="16x16" href="https://behaviorismandmentalhealth.com/favicon-16x16.png">
<link rel="icon" type="image/png" sizes="32x32" href="https://behaviorismandmentalhealth.com/favicon-32x32.png">
<link rel="apple-touch-icon" href="https://behaviorismandmentalhealth.com/apple-touch-icon.png">
<link rel="mask-icon" href="https://behaviorismandmentalhealth.com/safari-pinned-tab.svg">
<meta name="theme-color" content="#2e2e33">
<meta name="msapplication-TileColor" content="#2e2e33">
<link rel="alternate" hreflang="en" href="https://behaviorismandmentalhealth.com/posts/fda-goes-against-its-advisory-panel/">
<noscript>
    <style>
        #theme-toggle,
        .top-link {
            display: none;
        }

    </style>
    <style>
        @media (prefers-color-scheme: dark) {
            :root {
                --theme: rgb(29, 30, 32);
                --entry: rgb(46, 46, 51);
                --primary: rgb(218, 218, 219);
                --secondary: rgb(155, 156, 157);
                --tertiary: rgb(65, 66, 68);
                --content: rgb(196, 196, 197);
                --code-block-bg: rgb(46, 46, 51);
                --code-bg: rgb(55, 56, 62);
                --border: rgb(51, 51, 51);
            }

            .list {
                background: var(--theme);
            }

            .list:not(.dark)::-webkit-scrollbar-track {
                background: 0 0;
            }

            .list:not(.dark)::-webkit-scrollbar-thumb {
                border-color: var(--theme);
            }
        }

    </style>
</noscript><meta property="og:url" content="https://behaviorismandmentalhealth.com/posts/fda-goes-against-its-advisory-panel/">
  <meta property="og:site_name" content="Behaviorism and Mental Health">
  <meta property="og:title" content="FDA Goes Against Its Advisory Panel">
  <meta property="og:description" content="The FDA recently approved paroxetine (which in higher doses is marketed as the antidepressant Paxil) as a nonhormonal treatment for hot flashes in menopausal women. The drug will be marketed as Brisdelle.
According to a New York Times article F.D.A. Approves a Drug for Hot Flashes, the approval was granted despite the fact that FDA’s own advisory committee voted 10 to 4 last March against approval.
The reported reason for the negative vote was that in clinical trials, Brisdelle proved only minimally effective.">
  <meta property="og:locale" content="en-us">
  <meta property="og:type" content="article">
    <meta property="article:section" content="posts">
    <meta property="article:published_time" content="2013-07-03T04:38:32+00:00">
    <meta property="article:modified_time" content="2013-07-03T04:38:32+00:00">
<meta name="twitter:card" content="summary">
<meta name="twitter:title" content="FDA Goes Against Its Advisory Panel">
<meta name="twitter:description" content="The FDA recently approved paroxetine (which in higher doses is marketed as the antidepressant Paxil) as a nonhormonal treatment for hot flashes in menopausal women.  The drug will be marketed as Brisdelle.
According to a New York Times article F.D.A. Approves a Drug for Hot Flashes, the approval was granted despite the fact that FDA&rsquo;s own advisory committee voted 10 to 4 last March against approval.
The reported reason for the negative vote was that in clinical trials, Brisdelle proved only minimally effective.">


<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [
    {
      "@type": "ListItem",
      "position":  1 ,
      "name": "Posts",
      "item": "https://behaviorismandmentalhealth.com/posts/"
    }, 
    {
      "@type": "ListItem",
      "position":  2 ,
      "name": "FDA Goes Against Its Advisory Panel",
      "item": "https://behaviorismandmentalhealth.com/posts/fda-goes-against-its-advisory-panel/"
    }
  ]
}
</script>
<script type="application/ld+json">
{
  "@context": "https://schema.org",
  "@type": "BlogPosting",
  "headline": "FDA Goes Against Its Advisory Panel",
  "name": "FDA Goes Against Its Advisory Panel",
  "description": "The FDA recently approved paroxetine (which in higher doses is marketed as the antidepressant Paxil) as a nonhormonal treatment for hot flashes in menopausal women. The drug will be marketed as Brisdelle.\nAccording to a New York Times article F.D.A. Approves a Drug for Hot Flashes, the approval was granted despite the fact that FDA\u0026rsquo;s own advisory committee voted 10 to 4 last March against approval.\nThe reported reason for the negative vote was that in clinical trials, Brisdelle proved only minimally effective.\n",
  "keywords": [
    
  ],
  "articleBody": "The FDA recently approved paroxetine (which in higher doses is marketed as the antidepressant Paxil) as a nonhormonal treatment for hot flashes in menopausal women. The drug will be marketed as Brisdelle.\nAccording to a New York Times article F.D.A. Approves a Drug for Hot Flashes, the approval was granted despite the fact that FDA’s own advisory committee voted 10 to 4 last March against approval.\nThe reported reason for the negative vote was that in clinical trials, Brisdelle proved only minimally effective.\nBrisdelle apparently will be marketed with an “increased risk of suicidal thoughts and actions” label, but I wonder how many women who take the product will realize that they are taking a low dose of Paxil?\n",
  "wordCount" : "119",
  "inLanguage": "en",
  "datePublished": "2013-07-03T04:38:32Z",
  "dateModified": "2013-07-03T04:38:32Z",
  "author":{
    "@type": "Person",
    "name": "PhilHickeyPhD"
  },
  "mainEntityOfPage": {
    "@type": "WebPage",
    "@id": "https://behaviorismandmentalhealth.com/posts/fda-goes-against-its-advisory-panel/"
  },
  "publisher": {
    "@type": "Organization",
    "name": "Behaviorism and Mental Health",
    "logo": {
      "@type": "ImageObject",
      "url": "https://behaviorismandmentalhealth.com/favicon.ico"
    }
  }
}
</script>
</head>

<body class="" id="top">
<script>
    if (localStorage.getItem("pref-theme") === "dark") {
        document.body.classList.add('dark');
    } else if (localStorage.getItem("pref-theme") === "light") {
        document.body.classList.remove('dark')
    } else if (window.matchMedia('(prefers-color-scheme: dark)').matches) {
        document.body.classList.add('dark');
    }

</script>

<header class="header">
    <nav class="nav">
        <div class="logo">
            <a href="https://behaviorismandmentalhealth.com/" accesskey="h" title="Behaviorism and Mental Health (Alt + H)">Behaviorism and Mental Health</a>
            <div class="logo-switches">
                <button id="theme-toggle" accesskey="t" title="(Alt + T)" aria-label="Toggle theme">
                    <svg id="moon" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <path d="M21 12.79A9 9 0 1 1 11.21 3 7 7 0 0 0 21 12.79z"></path>
                    </svg>
                    <svg id="sun" xmlns="http://www.w3.org/2000/svg" width="24" height="18" viewBox="0 0 24 24"
                        fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round"
                        stroke-linejoin="round">
                        <circle cx="12" cy="12" r="5"></circle>
                        <line x1="12" y1="1" x2="12" y2="3"></line>
                        <line x1="12" y1="21" x2="12" y2="23"></line>
                        <line x1="4.22" y1="4.22" x2="5.64" y2="5.64"></line>
                        <line x1="18.36" y1="18.36" x2="19.78" y2="19.78"></line>
                        <line x1="1" y1="12" x2="3" y2="12"></line>
                        <line x1="21" y1="12" x2="23" y2="12"></line>
                        <line x1="4.22" y1="19.78" x2="5.64" y2="18.36"></line>
                        <line x1="18.36" y1="5.64" x2="19.78" y2="4.22"></line>
                    </svg>
                </button>
            </div>
        </div>
        <ul id="menu">
            <li>
                <a href="https://behaviorismandmentalhealth.com/categories/" title="Categories">
                    <span>Categories</span>
                </a>
            </li>
        </ul>
    </nav>
</header>
<main class="main">

<article class="post-single">
  <header class="post-header">
    
    <h1 class="post-title entry-hint-parent">
      FDA Goes Against Its Advisory Panel
    </h1>
    <div class="post-meta"><span title='2013-07-03 04:38:32 +0000 UTC'>July 3, 2013</span>&nbsp;·&nbsp;PhilHickeyPhD

</div>
  </header> 
  <div class="post-content"><p>The FDA recently approved paroxetine (which in higher doses is marketed as the antidepressant Paxil) as a nonhormonal treatment for hot flashes in menopausal women.  The drug will be marketed as Brisdelle.</p>
<p>According to a New York Times article <i><a href="http://www.nytimes.com/2013/06/29/business/fda-approves-a-drug-for-hot-flashes.html?_r=0">F.D.A. Approves a Drug for Hot Flashes</a>, </i>the approval was granted despite the fact that FDA&rsquo;s own advisory committee voted 10 to 4 last March <i>against approval.</i></p>
<p>The reported reason for the negative vote was that in clinical trials, <strong>Brisdelle proved only minimally effective</strong>.</p>
<p>Brisdelle apparently will be marketed with an &ldquo;increased risk of suicidal thoughts and actions&rdquo;  label, but I wonder how many women who take the product will realize that they are taking a low dose of Paxil?</p>
<p> </p>


  </div>

  <footer class="post-footer">
    <ul class="post-tags">
    </ul>
  </footer>
</article>
    </main>
    
<footer class="footer">
        <span>&copy; 2025 <a href="https://behaviorismandmentalhealth.com/">Behaviorism and Mental Health</a></span> · 

    <span>
        Powered by
        <a href="https://gohugo.io/" rel="noopener noreferrer" target="_blank">Hugo</a> &
        <a href="https://github.com/adityatelange/hugo-PaperMod/" rel="noopener" target="_blank">PaperMod</a>
    </span>
</footer>
<a href="#top" aria-label="go to top" title="Go to Top (Alt + G)" class="top-link" id="top-link" accesskey="g">
    <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 12 6" fill="currentColor">
        <path d="M12 6H0l6-6z" />
    </svg>
</a>

<script>
    let menu = document.getElementById('menu')
    if (menu) {
        menu.scrollLeft = localStorage.getItem("menu-scroll-position");
        menu.onscroll = function () {
            localStorage.setItem("menu-scroll-position", menu.scrollLeft);
        }
    }

    document.querySelectorAll('a[href^="#"]').forEach(anchor => {
        anchor.addEventListener("click", function (e) {
            e.preventDefault();
            var id = this.getAttribute("href").substr(1);
            if (!window.matchMedia('(prefers-reduced-motion: reduce)').matches) {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView({
                    behavior: "smooth"
                });
            } else {
                document.querySelector(`[id='${decodeURIComponent(id)}']`).scrollIntoView();
            }
            if (id === "top") {
                history.replaceState(null, null, " ");
            } else {
                history.pushState(null, null, `#${id}`);
            }
        });
    });

</script>
<script>
    var mybutton = document.getElementById("top-link");
    window.onscroll = function () {
        if (document.body.scrollTop > 800 || document.documentElement.scrollTop > 800) {
            mybutton.style.visibility = "visible";
            mybutton.style.opacity = "1";
        } else {
            mybutton.style.visibility = "hidden";
            mybutton.style.opacity = "0";
        }
    };

</script>
<script>
    document.getElementById("theme-toggle").addEventListener("click", () => {
        if (document.body.className.includes("dark")) {
            document.body.classList.remove('dark');
            localStorage.setItem("pref-theme", 'light');
        } else {
            document.body.classList.add('dark');
            localStorage.setItem("pref-theme", 'dark');
        }
    })

</script>
</body>

</html>
